FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087341156> ?p ?o ?g. }

• W3087341156 abstract "Abstract Background Osteoarthritis (OA) is a common chronic disease in older adults. Currently, there are no effective therapies to reduce disease severity and progression of knee OA (KOA), particularly in mid- to late-stages. This study aims to examine the effect of methotrexate (MTX) on knee effusion-synovitis and pain in symptomatic patients with mid- to late-stage KOA. Methods/design This protocol describes a multicentre randomised placebo-controlled clinical trial aiming to recruit 200 participants with mid- to late-stage symptomatic KOA and with effusion-synovitis grade of ≥ 2. Participants will be randomly allocated to the MTX group (start from 5 mg per week for the first 2 weeks and increase to 10 mg per week for the second 2 weeks and 15 mg per week for the remaining period if tolerated) or the placebo group. Primary outcomes are effusion-synovitis size measured by magnetic resonance imaging (MRI) and knee pain assessed by visual analogue scale (VAS). Secondary outcomes are signal intensity alteration within infrapatellar fat pad (IPFP) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) total score and subscores, and the Outcome Measures in Rheumatology Arthritis Clinical Trials-Osteoarthritis Research Society International (OMERACT-OARSI) responders. Both intention-to-treat and per-protocol analyses will be performed. Discussion If MTX intervention can relieve symptoms and reduce inflammation in patients with mid- to late-stage KOA, it has the potential for significant clinical and public health impact as this low-cost and commonly used intervention would delay the time to knee replacement, leading to substantial cost savings and improve quality of life. Trial registration ClinicalTrials.gov NCT03815448 . Registered on 21 January 2019." @default.
• W3087341156 created "2020-09-25" @default.
• W3087341156 creator A5004518102 @default.
• W3087341156 creator A5029946717 @default.
• W3087341156 creator A5039342892 @default.
• W3087341156 creator A5039679140 @default.
• W3087341156 creator A5040192354 @default.
• W3087341156 creator A5040602611 @default.
• W3087341156 creator A5047388413 @default.
• W3087341156 creator A5047768349 @default.
• W3087341156 creator A5047873063 @default.
• W3087341156 creator A5052150483 @default.
• W3087341156 creator A5056374478 @default.
• W3087341156 creator A5073523669 @default.
• W3087341156 creator A5074247805 @default.
• W3087341156 creator A5075795661 @default.
• W3087341156 creator A5080186087 @default.
• W3087341156 creator A5080921373 @default.
• W3087341156 creator A5090372525 @default.
• W3087341156 date "2020-09-16" @default.
• W3087341156 modified "2023-10-12" @default.
• W3087341156 title "Can low-dose methotrexate reduce effusion-synovitis and symptoms in patients with mid- to late-stage knee osteoarthritis? Study protocol for a randomised, double-blind, and placebo-controlled trial" @default.
• W3087341156 cites W1847660697 @default.
• W3087341156 cites W1974109379 @default.
• W3087341156 cites W1975536411 @default.
• W3087341156 cites W1979871017 @default.
• W3087341156 cites W1987537066 @default.
• W3087341156 cites W1988436413 @default.
• W3087341156 cites W1991947119 @default.
• W3087341156 cites W2009524387 @default.
• W3087341156 cites W2017869529 @default.
• W3087341156 cites W2021234773 @default.
• W3087341156 cites W2028014480 @default.
• W3087341156 cites W2028591423 @default.
• W3087341156 cites W2032701015 @default.
• W3087341156 cites W2042215069 @default.
• W3087341156 cites W2042301948 @default.
• W3087341156 cites W2053342448 @default.
• W3087341156 cites W2066659898 @default.
• W3087341156 cites W2078828283 @default.
• W3087341156 cites W2088598729 @default.
• W3087341156 cites W2089773409 @default.
• W3087341156 cites W2102838907 @default.
• W3087341156 cites W2105596400 @default.
• W3087341156 cites W2108008334 @default.
• W3087341156 cites W2109228592 @default.
• W3087341156 cites W2112861894 @default.
• W3087341156 cites W2119527637 @default.
• W3087341156 cites W2121544294 @default.
• W3087341156 cites W2132322340 @default.
• W3087341156 cites W2133359158 @default.
• W3087341156 cites W2135699169 @default.
• W3087341156 cites W2147359691 @default.
• W3087341156 cites W2154155433 @default.
• W3087341156 cites W2159453342 @default.
• W3087341156 cites W2160745547 @default.
• W3087341156 cites W2161256419 @default.
• W3087341156 cites W2161471390 @default.
• W3087341156 cites W2168014183 @default.
• W3087341156 cites W2304915985 @default.
• W3087341156 cites W2337524788 @default.
• W3087341156 cites W2362808 @default.
• W3087341156 cites W2551457835 @default.
• W3087341156 cites W2762964021 @default.
• W3087341156 cites W2891966381 @default.
• W3087341156 cites W2899288218 @default.
• W3087341156 doi "https://doi.org/10.1186/s13063-020-04687-3" @default.
• W3087341156 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7493135" @default.
• W3087341156 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32938470" @default.
• W3087341156 hasPublicationYear "2020" @default.
• W3087341156 type Work @default.
• W3087341156 sameAs 3087341156 @default.
• W3087341156 citedByCount "6" @default.
• W3087341156 countsByYear W30873411562021 @default.
• W3087341156 countsByYear W30873411562022 @default.
• W3087341156 countsByYear W30873411562023 @default.
• W3087341156 crossrefType "journal-article" @default.
• W3087341156 hasAuthorship W3087341156A5004518102 @default.
• W3087341156 hasAuthorship W3087341156A5029946717 @default.
• W3087341156 hasAuthorship W3087341156A5039342892 @default.
• W3087341156 hasAuthorship W3087341156A5039679140 @default.
• W3087341156 hasAuthorship W3087341156A5040192354 @default.
• W3087341156 hasAuthorship W3087341156A5040602611 @default.
• W3087341156 hasAuthorship W3087341156A5047388413 @default.
• W3087341156 hasAuthorship W3087341156A5047768349 @default.
• W3087341156 hasAuthorship W3087341156A5047873063 @default.
• W3087341156 hasAuthorship W3087341156A5052150483 @default.
• W3087341156 hasAuthorship W3087341156A5056374478 @default.
• W3087341156 hasAuthorship W3087341156A5073523669 @default.
• W3087341156 hasAuthorship W3087341156A5074247805 @default.
• W3087341156 hasAuthorship W3087341156A5075795661 @default.
• W3087341156 hasAuthorship W3087341156A5080186087 @default.
• W3087341156 hasAuthorship W3087341156A5080921373 @default.
• W3087341156 hasAuthorship W3087341156A5090372525 @default.
• W3087341156 hasBestOaLocation W30873411561 @default.
• W3087341156 hasConcept C126322002 @default.
• W3087341156 hasConcept C126838900 @default.
• W3087341156 hasConcept C141071460 @default.
• W3087341156 hasConcept C14184104 @default.
• W3087341156 hasConcept C142724271 @default.

• next